Concepedia

Author

William R. Berry

Texas Oncology

Also Known As

W Berry, W R Berry, W. Berry, W. R. Berry, W.R. Berry, WILLIAM BERRY, WILLIAM R. BERRY, William Berry, William R Berry, William R. Berry

32

Publications

6.4K

Citations

14

H-Index

25

Concepts

All Affiliations

Texas OncologyHôpital Européen Georges-Pompidou
WR

About

William R. Berry is an author at Texas Oncology specializing in medicine, oncology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

309

2

Health Sciences

3

3

221

3

Engineering

1

1

19

4

Diagnostic Sciences

1

1

166

5

Orthopaedics

1

1

41

William R. Berry

×

12

Publications

6.4K

Citations

12

H-Index

YearCitations

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

Ian F. Tannock, Ronald de Wit, William R. Berry,

New England Journal of Medicine

2004

5.7K

Phase III Study of Mitoxantrone Plus Low Dose Prednisone Versus Low Dose Prednisone Alone in Patients With Asymptomatic Hormone Refractory Prostate Cancer

William R. Berry, Shaker R. Dakhil, Manuel Modiano,

The Journal of Urology

2002

166

Phase III study of mitoxantrone plus low dose prednisone versus low dose prednisone alone in patients with asymptomatic hormone refractory prostate cancer.

William R. Berry, Shaker R. Dakhil, Manuel Modiano,

PubMed

2002

158

Hypophosphatemic Osteomalacia: Association with Prostatic Carcinoma

Kenneth W. Lyles, William R. Berry, Mark R. Haussler,

Annals of Internal Medicine

1980

118

Amifostine, cisplatin, and vinblastine in metastatic non-small-cell lung cancer: a report of high response rates and prolonged survival.

Joan H. Schiller, Barry E. Storer, Jordan Berlin,

Journal of Clinical Oncology

1996

72

Phase II Randomized Trial of Weekly Paclitaxel with or Without Estramustine Phosphate in Progressive, Metastatic, Hormone-Refractory Prostate Cancer

William R. Berry, James W. Hathorn, Shaker R. Dakhil,

Clinical Prostate Cancer

2004

43

Satraplatin in patients with advanced hormone-refractory prostate cancer (HRPC): Overall survival (OS) results from the phase III satraplatin and prednisone against refractory cancer (SPARC) trial

Oliver Sartor, Daniel P. Petrylak, J.A. Witjes,

Journal of Clinical Oncology

2008

41

European investigation of clustered plug nozzles

Didier Vuillamy, Vianney Duthoit, William R. Berry

35th Joint Propulsion Conference and Exhibit

1999

19

Nitrofurantoin-induced cholestatic hepatitis from cow's milk in a teenaged boy.

William R. Berry, G. H. Warren, J. Reichen

PubMed

1984

16

Results of a Phase II Study of Weekly Paclitaxel Plus Carboplatin in Advanced Carcinoma of Unknown Primary Origin: A Reasonable Regimen for the Community-Based Clinic?

William R. Berry, Maha Elkordy, Mark Allen O’Rourke,

Cancer Investigation

2007

15

Page 1